{"schema_version":"secwatch.filing_event.v1","accession":"0001472375-26-000214","form_type":"8-K","ticker":"RGPX","cik":"0001357878","company_name":"REGENEREX PHARMA, INC.","filed_at":"2026-09-01T18:13:08+00:00","discovered_at":"2026-09-01T18:14:00.419218+00:00","generated_at":"2026-09-01T18:14:07.888527+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Regenerex Pharma discloses delinquent Q1/Q2 2026 10-Qs; 10-K filed late","bullets":["2025 Form 10-K filed after deadline; Q1 and Q2 2026 10-Qs not yet filed and delinquent.","Company did not file Form 12b-25 notifications for the outstanding quarterly reports.","Delay attributed to additional accounting, reconciliation, and review work related to 10-K and quarterly statements.","Management working to complete and file outstanding reports as soon as practicable; no expected change to operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001472375-26-000214","json":"https://secwatch.observer/filing/0001472375-26-000214.json","markdown":"https://secwatch.observer/filing/0001472375-26-000214.md","text":"https://secwatch.observer/filing/0001472375-26-000214.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357878/000147237526000214/0001472375-26-000214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357878/000147237526000214/ixform8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T18:14:07.888527+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}